SignalCorporate
CollPlant Biotechnologies GAAP EPS of -$0.87, revenue of $11.43M; reaffirms FY 2026 outlook
CollPlant's EPS miss and $11.43M revenue with reaffirmed FY 2026 outlook drive this alert.
What changed
CollPlant's EPS miss and $11.43M revenue with reaffirmed FY 2026 outlook drive this alert.
Why it matters
CollPlant's EPS miss and $11.43M revenue with reaffirmed FY 2026 outlook drive this alert. — impact context not separately stored; see What changed.